Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Income from Continuing Operations (2021 - 2025)

Coeptis Therapeutics Holdings has reported Income from Continuing Operations over the past 5 years, most recently at 1622902.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 1622902.0 for Q4 2025, up 46.11% from a year ago — trailing twelve months through Dec 2025 was 12277192.0 (down 12.87% YoY), and the annual figure for FY2025 was 12277192.0, down 12.87%.
  • Income from Continuing Operations for Q4 2025 was 1622902.0 at Coeptis Therapeutics Holdings, up from 2898763.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for COEPW hit a ceiling of 100001.0 in Q3 2021 and a floor of 19179693.0 in Q1 2022.
  • Median Income from Continuing Operations over the past 5 years was 3118982.5 (2023), compared with a mean of 4801872.7.
  • Peak annual rise in Income from Continuing Operations hit 78.43% in 2022, while the deepest fall reached 13634.12% in 2022.
  • Coeptis Therapeutics Holdings' Income from Continuing Operations stood at 13646799.0 in 2021, then skyrocketed by 78.43% to 2942978.0 in 2022, then dropped by 27.61% to 3755589.0 in 2023, then rose by 19.81% to 3011765.0 in 2024, then surged by 46.11% to 1622902.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 1622902.0 (Q4 2025), 2898763.0 (Q3 2025), and 4334586.0 (Q2 2025) per Business Quant data.